Form D · Biotechnology
Evelo Biosciences, Inc.
Cambridge, MA · CIK 0001694665
Offering snapshot reported Mar 23, 2018 · SEC filing
- Reported sold
- $81.5M Offering amount: $81.5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 9, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$47,500,005 → $81,500,003
- Reported investors11 → 15
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2018 | Amendment | $81,500,003 | $33,999,998vs Feb 20, 2018 | 15 | SEC filing |
| Feb 20, 2018 | Initial | $47,500,005 | No comparison | 11 | SEC filing |
| Feb 12, 2018 | Amendment | $50,000,000 | $19,499,999vs Jan 18, 2017 | 11 | SEC filing |
| Jan 18, 2017 | Initial | $30,500,001 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-306045
Source: Form D, filed Mar 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Derek Adams | Executive |
| Noubar B. Afeyan, Ph.D. | Director |
| David A. Berry, M.D., Ph.D. | Director |
| Mark Bodmer, Ph.D. | Executive |
| Lord Ara Darzi | Director |
| William De Vaul | Executive |
| David R. Epstein | Director |
| Balkrishan (Simba) Gill, Ph.D. | Director, Executive |
| Jennifer Glennon | Executive |
| Duncan Mc Hale | Executive |
| Theodose Melas Kyriazi | Director |
| Jackie Papkoff | Executive |
| David P. Perry | Director |
| Mark Pruzanski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
620 Memorial Drive Suite 200 West
Cambridge, MA, 02139
Cambridge, MA, 02139